AVTE
Price
$2.37
Change
-$0.02 (-0.84%)
Updated
Feb 21 closing price
Capitalization
68.69M
31 days until earnings call
HALO
Price
$57.75
Change
+$0.31 (+0.54%)
Updated
Feb 21 closing price
Capitalization
7.11B
79 days until earnings call
Ad is loading...

AVTE vs HALO

Header iconAVTE vs HALO Comparison
Open Charts AVTE vs HALOBanner chart's image
Aerovate Therapeutics
Price$2.37
Change-$0.02 (-0.84%)
Volume$122.95K
Capitalization68.69M
Halozyme Therapeutics
Price$57.75
Change+$0.31 (+0.54%)
Volume$1.3M
Capitalization7.11B
AVTE vs HALO Comparison Chart
Loading...
AVTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVTE vs. HALO commentary
Feb 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTE is a Hold and HALO is a Buy.

Ad is loading...
COMPARISON
Comparison
Feb 24, 2025
Stock price -- (AVTE: $2.37 vs. HALO: $57.90)
Brand notoriety: AVTE and HALO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVTE: 150% vs. HALO: 123%
Market capitalization -- AVTE: $68.69M vs. HALO: $7.11B
AVTE [@Biotechnology] is valued at $68.69M. HALO’s [@Biotechnology] market capitalization is $7.11B. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTE’s FA Score shows that 1 FA rating(s) are green whileHALO’s FA Score has 2 green FA rating(s).

  • AVTE’s FA Score: 1 green, 4 red.
  • HALO’s FA Score: 2 green, 3 red.
According to our system of comparison, HALO is a better buy in the long-term than AVTE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTE’s TA Score shows that 3 TA indicator(s) are bullish while HALO’s TA Score has 2 bullish TA indicator(s).

  • AVTE’s TA Score: 3 bullish, 5 bearish.
  • HALO’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, AVTE is a better buy in the short-term than HALO.

Price Growth

AVTE (@Biotechnology) experienced а -4.05% price change this week, while HALO (@Biotechnology) price change was +0.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.27%. For the same industry, the average monthly price growth was +3.99%, and the average quarterly price growth was +2.35%.

Reported Earning Dates

AVTE is expected to report earnings on May 19, 2025.

HALO is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+4.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HALO($7.11B) has a higher market cap than AVTE($68.7M). HALO YTD gains are higher at: 20.791 vs. AVTE (-10.566). HALO has higher annual earnings (EBITDA): 580M vs. AVTE (-89.96M). HALO has more cash in the bank: 666M vs. AVTE (88.7M). AVTE has less debt than HALO: AVTE (540K) vs HALO (1.5B). HALO has higher revenues than AVTE: HALO (947M) vs AVTE (0).
AVTEHALOAVTE / HALO
Capitalization68.7M7.11B1%
EBITDA-89.96M580M-16%
Gain YTD-10.56620.791-51%
P/E RatioN/A16.84-
Revenue0947M-
Total Cash88.7M666M13%
Total Debt540K1.5B0%
FUNDAMENTALS RATINGS
HALO: Fundamental Ratings
HALO
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
25
SMR RATING
1..100
12
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
56
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVTEHALO
RSI
ODDS (%)
N/A
Bearish Trend 6 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
84%
Bearish Trend 6 days ago
69%
Momentum
ODDS (%)
Bearish Trend 6 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 6 days ago
88%
Bullish Trend 6 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 6 days ago
76%
Advances
ODDS (%)
Bullish Trend 25 days ago
82%
Bullish Trend 18 days ago
76%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
82%
Bearish Trend 6 days ago
73%
Aroon
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 6 days ago
75%
View a ticker or compare two or three
Ad is loading...
AVTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL245.55-0.28
-0.11%
Apple
BTC.X96258.000000-319.757800
-0.33%
Bitcoin cryptocurrency
SPY599.94-10.44
-1.71%
SPDR® S&P 500® ETF Trust
GME26.42-0.62
-2.29%
GameStop Corp
TSLA337.80-16.60
-4.68%
Tesla

AVTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTE has been closely correlated with OVID. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if AVTE jumps, then OVID could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTE
1D Price
Change %
AVTE100%
-0.84%
OVID - AVTE
90%
Closely correlated
+8.91%
NTLA - AVTE
47%
Loosely correlated
-0.65%
DNLI - AVTE
43%
Loosely correlated
-3.98%
BEAM - AVTE
41%
Loosely correlated
-8.18%
SNDX - AVTE
39%
Loosely correlated
+2.44%
More

HALO and

Correlation & Price change

A.I.dvisor indicates that over the last year, HALO has been loosely correlated with IDYA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if HALO jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HALO
1D Price
Change %
HALO100%
+0.54%
IDYA - HALO
37%
Loosely correlated
+0.55%
AVTE - HALO
35%
Loosely correlated
-0.84%
VIR - HALO
35%
Loosely correlated
-2.35%
DNLI - HALO
34%
Loosely correlated
-3.98%
RPRX - HALO
34%
Loosely correlated
+0.94%
More